IL37 and metabolic syndrome: Situations in which IL-37 attained clinically significant discriminating ability included the model of IL-37 and C-Reactive Protein in differentiating diabetic patients with low/normal–high BMI (<25/≥25 kg/m2), and the model of IL-37 and Thyroid Stimulating Hormone in discriminating between women with/without metabolic syndrome.